Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension
Rashna Khanna, Brandy R. Matthews, Dawn A. Brooks, Ivelina Gueorguieva et al.
Citations
1 citations
Journal
The Journal of Prevention of Alzheimer s Disease
Topics
Dementia and Cognitive Impairment Research
Field-Weighted Citation Impact (FWCI)
1.47
article
Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension
Rashna Khanna, Brandy R. Matthews, Dawn A. Brooks, Ivelina Gueorguieva, M Paget, Giulia Tronchin, Lars Lau Rakêt, Christophe Sapin, Emel Serap Monkul Nery, Mark A. Mintun, Shoichiro Sato, Hong Wang, Scott W. Andersen, Jennifer A. Zimmer, John R. Sims, Cynthia Evans, Paul Ardayfio, Alette M. Wessels
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Prevention of Alzheimer s DiseaseVol. 13(2)